Recent developments in diagnosis and assessment of morphea

Sarah Nouri, Heidi Jacobe

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


There is huge variation in the evaluation, diagnosis, and treatment of patients with morphea (localized scleroderma). In part, this variability results from the lack of validated methods to assess severity and outcomes with a consequent lack of adequate therapeutic trials. Evaluation is also hindered by lack of information regarding the impact of morphea on patients. Recent studies are addressing this gap in knowledge and include: development of clinical outcome measures, validation of imaging studies, publication of consensus treatment plans, and increased understanding of the impact of morphea on patients and parents. The purpose of this review is to summarize the results of these studies and to synthesize the information into a rational approach to the diagnosis and assessment of patients with morphea.

Original languageEnglish (US)
Article number308
JournalCurrent Rheumatology Reports
Issue number2
StatePublished - Feb 2013


  • Assessment
  • Autoantibodies
  • Diagnosis
  • Histology
  • Imaging
  • Linearscleroderma
  • Localized scleroderma
  • MRI
  • Morphea
  • Outcomemeasure
  • Ultrasound

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Recent developments in diagnosis and assessment of morphea'. Together they form a unique fingerprint.

Cite this